Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated:  12/31/1969
Altoona Center for Clinical Research
2201
mi
from 91732
Duncansville, PA
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated: 12/31/1969
Altoona Center for Clinical Research
2201
mi
from 91732
Duncansville, PA
Click here to add this to my saved trials
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated:  12/31/1969
Low Country Rheumatology
2184
mi
from 91732
Charleston, SC
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated: 12/31/1969
Low Country Rheumatology
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated:  12/31/1969
Tricounty Radiology
mi
from 91732
Charleston, SC
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated: 12/31/1969
Tricounty Radiology
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated:  12/31/1969
Accurate Clinical Research
1357
mi
from 91732
Houston, TX
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated: 12/31/1969
Accurate Clinical Research
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated:  12/31/1969
Arthritis Northwest
938
mi
from 91732
Spokane, WA
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated: 12/31/1969
Arthritis Northwest
938
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated:  12/31/1969
Revmatologichen kabinet, DKTs Sv. Pantaleimon OOD
mi
from 91732
Pleven,
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of Pf 04171327(1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug.
Status: Enrolling
Updated: 12/31/1969
Revmatologichen kabinet, DKTs Sv. Pantaleimon OOD
mi
from 91732
Pleven,
Click here to add this to my saved trials
Can Computer-based Telephone Counseling Improve Long-term Adherence to Strength Training in Elders With Knee OA?
Can Computer-based Telephone Counseling Improve Long-term Adherence to Strength Training in Elders With Knee Osteoarthritis (OA)?
Status: Enrolling
Updated:  12/31/1969
Boston University
2578
mi
from 91732
Boston, MA
Can Computer-based Telephone Counseling Improve Long-term Adherence to Strength Training in Elders With Knee OA?
Can Computer-based Telephone Counseling Improve Long-term Adherence to Strength Training in Elders With Knee Osteoarthritis (OA)?
Status: Enrolling
Updated: 12/31/1969
Boston University
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Agricultural Health Study Follow-up
Agricultural Health Study: Health Follow-up
Status: Enrolling
Updated:  12/31/1969
NIEHS, Research Triangle Park
2203
mi
from 91732
Research Triangle Park, NC
Agricultural Health Study Follow-up
Agricultural Health Study: Health Follow-up
Status: Enrolling
Updated: 12/31/1969
NIEHS, Research Triangle Park
2203
mi
from 91732
Research Triangle Park, NC
Click here to add this to my saved trials
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Arthritis Center, Johns Hopkins University
mi
from 91732
Baltimore, MD
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Arthritis Center, Johns Hopkins University
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Rheumatologist Hospital for Special Surgery
mi
from 91732
New York, NY
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Rheumatologist Hospital for Special Surgery
mi
from 91732
New York, NY
Click here to add this to my saved trials
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Division of Rheumatology, Columbia University, College of Physicians and Surgeons
mi
from 91732
New York, NY
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Division of Rheumatology, Columbia University, College of Physicians and Surgeons
mi
from 91732
New York, NY
Click here to add this to my saved trials
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Division of Allergy, Immunology and Rheumatology, University of Rochester
mi
from 91732
Rochester, NY
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Division of Allergy, Immunology and Rheumatology, University of Rochester
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Seattle Rheumatology Associates
961
mi
from 91732
Seattle, WA
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Seattle Rheumatology Associates
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
University of Calgary
mi
from 91732
Calgary,
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
University of Calgary
mi
from 91732
Calgary,
Click here to add this to my saved trials
Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty
Retrospective and Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Humeral Stem
Status: Enrolling
Updated:  12/31/1969
Norton Orthopaedic Specialists
1812
mi
from 91732
Louisville, KY
Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty
Retrospective and Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Humeral Stem
Status: Enrolling
Updated: 12/31/1969
Norton Orthopaedic Specialists
1812
mi
from 91732
Louisville, KY
Click here to add this to my saved trials
Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty
Retrospective and Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Humeral Stem
Status: Enrolling
Updated:  12/31/1969
Rothman Institute
2375
mi
from 91732
Philadelphia, PA
Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty
Retrospective and Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Humeral Stem
Status: Enrolling
Updated: 12/31/1969
Rothman Institute
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty
Retrospective and Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Humeral Stem
Status: Enrolling
Updated:  12/31/1969
William Beaumont Hospital
1960
mi
from 91732
Royal Oak, MI
Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty
Retrospective and Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Humeral Stem
Status: Enrolling
Updated: 12/31/1969
William Beaumont Hospital
1960
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
Orthopaedic Specialty Institute
21
mi
from 91732
Orange, CA
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
Orthopaedic Specialty Institute
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
UCSD Medical Center
105
mi
from 91732
San Diego, CA
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
UCSD Medical Center
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
Orthopaedic Center of the Rockies
839
mi
from 91732
Fort Collins, CO
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
Orthopaedic Center of the Rockies
839
mi
from 91732
Fort Collins, CO
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
Heekin Institute for Orthopedic Research, Inc.
2128
mi
from 91732
Jacksonville, FL
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
Heekin Institute for Orthopedic Research, Inc.
2128
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
The Arthroplasty Foundation
1812
mi
from 91732
Louisville, KY
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
The Arthroplasty Foundation
1812
mi
from 91732
Louisville, KY
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
Tulane University Hospital & Clinic
1655
mi
from 91732
New Orleans, LA
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
Tulane University Hospital & Clinic
1655
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
Hip and Knee Research of Nevada
213
mi
from 91732
Las Vegas, NV
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
Hip and Knee Research of Nevada
213
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
Dartmouth Medical School/Dartmouth-Hitchcock Medical Center
2515
mi
from 91732
Lebanon, NH
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
Dartmouth Medical School/Dartmouth-Hitchcock Medical Center
2515
mi
from 91732
Lebanon, NH
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
Cardinal Orthopaedic Institute
1960
mi
from 91732
Columbus, OH
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
Cardinal Orthopaedic Institute
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
Anderson Orthopaedic Research Institute
2281
mi
from 91732
Alexandria, VA
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
Anderson Orthopaedic Research Institute
2281
mi
from 91732
Alexandria, VA
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
Swedish Orthopedic Institute
961
mi
from 91732
Seattle, WA
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
Swedish Orthopedic Institute
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated:  12/31/1969
Hornsby Ku-ring-gai Hospital
7513
mi
from 91732
Hornsby,
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
Status: Enrolling
Updated: 12/31/1969
Hornsby Ku-ring-gai Hospital
7513
mi
from 91732
Hornsby,
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1784
mi
from 91732
Birmingham, AL
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1784
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1748
mi
from 91732
Tuscaloosa, AL
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1748
mi
from 91732
Tuscaloosa, AL
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
427
mi
from 91732
Tucson, AZ
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
427
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1423
mi
from 91732
Hot Springs, AR
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1423
mi
from 91732
Hot Springs, AR
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
13
mi
from 91732
Fullerton, CA
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
13
mi
from 91732
Fullerton, CA
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
105
mi
from 91732
La Mesa, CA
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
105
mi
from 91732
La Mesa, CA
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
56
mi
from 91732
Menifee, CA
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
56
mi
from 91732
Menifee, CA
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
368
mi
from 91732
Roseville, CA
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
368
mi
from 91732
Roseville, CA
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
364
mi
from 91732
Sacramento, CA
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
364
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
28
mi
from 91732
Van Nuys, CA
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
28
mi
from 91732
Van Nuys, CA
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2384
mi
from 91732
Lewes, DE
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2384
mi
from 91732
Lewes, DE
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2319
mi
from 91732
Aventura, FL
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2319
mi
from 91732
Aventura, FL
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2315
mi
from 91732
Fort Lauderdale, FL
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2315
mi
from 91732
Fort Lauderdale, FL
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2103
mi
from 91732
Gainesville, FL
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2103
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2261
mi
from 91732
Vero Beach, FL
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2261
mi
from 91732
Vero Beach, FL
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
941
mi
from 91732
Coeur D'Alene, ID
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
941
mi
from 91732
Coeur D'Alene, ID
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1718
mi
from 91732
Maywood, IL
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1718
mi
from 91732
Maywood, IL
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1881
mi
from 91732
Lexington, KY
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1881
mi
from 91732
Lexington, KY
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2301
mi
from 91732
Baltimore, MD
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1858
mi
from 91732
Battle Creek, MI
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1858
mi
from 91732
Battle Creek, MI
Click here to add this to my saved trials